The Flow Cytometry Shared Resource (FCSR) was established at Duke in 1979 to support investigators conducting basic, translational and clinical cancer research. The FCSR operates, maintains, and upgrades instrumentation for flow cytometric analysis and cell sorting of cells prepared by investigators and brought to the FCSR. The experienced staff of four performs almost all of the cell sorting and a small percentage of cell analysis, most of which is performed by facility users after being trained. The FCSR provides four analyzers, four cell sorters and one image cytometer: these cytometers are available at all times to all DCI members. Whether staff-run or self-run, fees are charged to partially offset operating expenses; DCI members receive a 40% discount across the board. In addition to cell sorting, acquiring, analyzing, archiving, and preparing flow data for publication, the FSCR staff provides consultation, technical advice, collaboration, and maintains a library to disseminate technical information to potential users. The FCSR staff has experience in nearly all areas of flow cytometric analysis and cell sorting applications and has helped investigators develop a variety of new applications. Staff members recommend assays, help develop and troubleshoot new protocols, participate actively in data analysis, and, in general, work closely with investigators to fine tune their individual experiments. The FCSR staff works integrally with investigators at all levels of experience and expertise to solve problems and meet investigators' scientific needs. Our services offered are commensurate with other facilities in the Southeast and our rates are quite competitive. We have kept our rates low for sorting cells, collecting data for analysis, or analyzing data, while at the same time not charging for consultation, project development, or cancelled appointments. While a small year-over-year decline in usage occurred in 2012, 2012 usage was still 11% higher than in 2009. Our use patterns in the coming years may be affected by stagnation of the NIH and other funders' budgets, which affect our users' ability to develop new lines of investigation and potential new users' ability to expand their work to include flow cytometry. However, even against that unknown, we expect a steady but modest increase in usage. In the past 12 months, 91 of our 146 users were DCI members, 85 of whom had peer-reviewed funding. Our DCI-member users represent all nine DCI research programs. Our long-term objectives are to continue to strategically incorporate new technologies and instruments that become available and that are needed to meet DCI members' needs and to continue to offer high quality, cost-effective service and expertise in flow cytometry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-44
Application #
9404297
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
44
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031
Wen, Juyi; Liu, Hongliang; Wang, Lili et al. (2018) Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. J Thorac Oncol 13:660-675
Li, Bo; Wang, Yanru; Xu, Yinghui et al. (2018) Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer 142:2303-2312
Gearhart-Serna, Larisa M; Jayasundara, Nishad; Tacam Jr, Moises et al. (2018) Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations. J Environ Public Health 2018:5610462
Bakthavatsalam, Subha; Sleeper, Mark L; Dharani, Azim et al. (2018) Leveraging ?-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells. Angew Chem Int Ed Engl 57:12780-12784
Dai, Ziwei; Mentch, Samantha J; Gao, Xia et al. (2018) Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width. Nat Commun 9:1955
Powell Gray, Bethany; Kelly, Linsley; Ahrens, Douglas P et al. (2018) Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer. Proc Natl Acad Sci U S A 115:4761-4766

Showing the most recent 10 out of 513 publications